Register Login

COMPASS Pathways plc (CMPS)

  • Event
  • July 19, 2022, 12:05 UTC

(10% Negative) COMPASS PATHWAYS PLC (CMPS) Announces Delay in experience Trials for mental health Due to Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 3:38 p.m.

    📋 COMPASS PATHWAYS PLC (CMPS) - Clinical Trial Update

    Filing Date: 2022-07-19

    Accepted: 2022-07-19 08:05:24

    Event Type: Clinical Trial Update

    Event Details:

    COMPASS Pathways plc (CMPS) Announces Clinical Trial Update COMPASS Pathways plc (CMPS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: experience, medicines
    • Diseases/Conditions: mental health
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: the University of Cambridge

    🔬 Clinical Development Pipeline (COMPASS PATHWAYS PLC):

    Product Type Development Stage Therapeutic Area Source
    Psilocybin DRUG Phase PHASE2 Anorexia Nervosa ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: COMPASS Pathways plc
    • CIK: 0001816590
    • Ticker Symbol: CMPS
    • Period End Date: 2022-07-19
    • Document Type: 8-K

Search

News categories